Modeling the regional spread and control of vancomycin-resistant enterococci

Am J Infect Control. 2013 Aug;41(8):668-73. doi: 10.1016/j.ajic.2013.01.013.

Abstract

Background: Because patients can remain colonized with vancomycin-resistant enterococci (VRE) for long periods of time, VRE may spread from one health care facility to another.

Methods: Using the Regional Healthcare Ecosystem Analyst, an agent-based model of patient flow among all Orange County, California, hospitals and communities, we quantified the degree and speed at which changes in VRE colonization prevalence in a hospital may affect prevalence in other Orange County hospitals.

Results: A sustained 10% increase in VRE colonization prevalence in any 1 hospital caused a 2.8% (none to 62%) average relative increase in VRE prevalence in all other hospitals. Effects took from 1.5 to >10 years to fully manifest. Larger hospitals tended to have greater affect on other hospitals.

Conclusions: When monitoring and controlling VRE, decision makers may want to account for regional effects. Knowing a hospital's connections with other health care facilities via patient sharing can help determine which hospitals to include in a surveillance or control program.

Keywords: Health care-associated infections; Hospitals; Modeling; Simulation; Vancomycin-resistant Enterococcus.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • California / epidemiology
  • Computer Simulation*
  • Cross Infection / epidemiology
  • Cross Infection / prevention & control*
  • Cross Infection / transmission*
  • Enterococcus / drug effects*
  • Gram-Positive Bacterial Infections / epidemiology
  • Gram-Positive Bacterial Infections / microbiology
  • Gram-Positive Bacterial Infections / prevention & control
  • Gram-Positive Bacterial Infections / transmission
  • Hospitals
  • Humans
  • Infection Control / methods*
  • Prevalence
  • Vancomycin / pharmacology
  • Vancomycin Resistance / drug effects*

Substances

  • Anti-Bacterial Agents
  • Vancomycin